Thrombin-generating capacity in patients with von Willebrand's disease

被引:54
作者
Rugeri, Lucia [1 ,2 ]
Beguin, Suzette [3 ]
Hemker, Coenraad [3 ]
Bordet, Jean-Claude [2 ,4 ]
Fleury, Raphael [1 ]
Chatard, Brigitte [2 ]
Negrier, Claude [1 ,2 ,4 ]
Dargaud, Yesim [1 ,2 ,4 ]
机构
[1] Hop Edouard Herriot, Unite Hemostase Clin, Pavillon E 5,Pl Arsonval, F-69003 Lyon, France
[2] Hop Edouard Herriot, Lab Hemostase, Lyon, France
[3] Univ Maastricht, Synapse Bv, CARIM, Maastricht, Netherlands
[4] Univ Lyon 1, EA 3735, Lyon, France
关键词
von Willebrand's disease; factor VIII; thrombin generation assay; bleeding phenotype; von Willebrand factor;
D O I
10.3324/haematol.11460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives von Willebrand's disease (VWD) is the most common hereditary bleeding disorder. Its severity can be classified on the basis of von Willebrand factor (VWF) and factor VIII (FVIII) plasma levels and according to the clinical relevance of bleeding episodes. However, patients with very low VWF activity may exhibit a mild bleeding tendency. The basis for this heterogeneous clinical expression of the deficit is still poorly understood. We investigated the relationship between thrombin generation and levels of factor VIII, VWF and clinical bleeding tendency. Design and Methods Thrombin generation was measured in platelet-rich (PRP) and platelet-poor plasma (PPP) from 53 patients with VWD. Results We observed a statistically significant higher risk of bleeding in patients with a low thrombin peak in PRP (OR=14.5; 95% CI=5-41.3). Similar results were found in PPP (OR=8.71; 95% CI=3.4-22.3). Two parameters of the thrombin generation curve, peak height and thrombin generation speed (slope), correlated significantly with VWF:RCo and FVIII levels both in PPP and in PRP Regression analysis showed that thrombin generation was mainly dependent on plasma FVIII activity. Interpretation and Conclusions Our results suggest that the thrombin generation test, in combination with routine FVIII and VWF measurements, could be of interest in the assessment of the individual bleeding risk in patients with VWD.
引用
收藏
页码:1639 / 1646
页数:8
相关论文
共 50 条
  • [21] Von Willebrand's disease in the German shepherd dog
    Lobetti, RG
    Dippenaar, T
    JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION-TYDSKRIF VAN DIE SUID-AFRIKAANSE VETERINERE VERENIGING, 2000, 71 (02): : 118 - 121
  • [22] THE INCIDENCE OF IMPAIRED BINDING CAPACITY OF VON WILLEBRAND FACTOR TO COLLAGEN TYPES I AND III IN PATIENTS WITH TYPE 1 VON WILLEBRAND DISEASE
    Koloskov, A., V
    Vasileva, M. Yu
    Philippova, O., I
    Chernova, E., V
    Beliaeva, E. L.
    Marchenko, V. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2023, 68 (01): : 62 - 69
  • [23] Von Willebrand Factor and von Willebrand disease: new approaches to diagnosis
    Ines Woods, Adriana
    Noemi Blanco, Alicia
    Catalina Kempfer, Ana
    Paiva, Juvenal
    Ines Bermejo, Emilse
    Sanchez Luceros, Analia
    Angela Lazzari, Maria
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (02): : 273 - 289
  • [24] von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
    Sanders, Yvonne V.
    Groeneveld, Dafna
    Meijer, Karina
    Fijnvandraat, Karin
    Cnossen, Marjon H.
    van der Bom, Johanna G.
    Coppens, M.
    de Meris, Joke
    Laros-van Gorkom, Britta A. P.
    Mauser-Bunschoten, Eveline P.
    Leebeek, Frank W. G.
    Eikenboom, Jeroen
    BLOOD, 2015, 125 (19) : 3006 - 3013
  • [25] Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
    Castaman, Giancarlo
    Linari, Silvia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1029 - 1037
  • [26] Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay
    Miller, Connie H.
    HAEMOPHILIA, 2021, 27 (05) : 823 - 829
  • [27] von Willebrand disease biology
    Blomback, M.
    Eikenboom, J.
    Lane, D.
    Denis, C.
    Lillicrap, D.
    HAEMOPHILIA, 2012, 18 : 141 - 147
  • [28] Treatment of von Willebrand disease
    Mannucci, PM
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (01) : 149 - 153
  • [29] Complications After TKA in Patients With Hemophilia or Von Willebrand's Disease
    Cancienne, Jourdan M.
    Werner, Brian C.
    Browne, James A.
    JOURNAL OF ARTHROPLASTY, 2015, 30 (12) : 2285 - 2289
  • [30] Hemoctin SDT treatment of patients with hemophilia A and von Willebrand's disease
    Kopylov, K. G.
    Plyushch, O. P.
    Likhachyova, E. A.
    Velichko, I. V.
    Severova, T. V.
    Zozulya, N. I.
    Tentsova, I. A.
    Ivanova, V. L.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (01): : 17 - +